Key Takeaways

• Almirall announces a comprehensive sustainability strategy, Act4Impact 2030, focusing on Planet, People, Patients, Partners, and Principles.
• The strategy aims to achieve net-zero emissions by 2050 and especially reduce environmental impact.
• Almirall prioritises diversity, equity, and inclusion initiatives within its workforce.
• Patient engagement strengthens with a focus on exceeding 1.8 million positively impacted individuals by 2030.
• Ethical and transparent corporate culture remains a cornerstone of Almirall's commitment.

Global pharmaceutical leader Almirall has announced its ambitious Act4Impact 2030 strategy, outlining a transformative roadmap for a more sustainable future.

This comprehensive approach focuses on five key pillars: Planet, People, Patients, Partners, and Principles.

Act4Impact 2030 prioritises environmental responsibility with a commitment to achieving net-zero emissions by 2050. To get there, Almirall sets ambitious near-term goals, including a 50% reduction in emissions from its operations and a 28% reduction from its value chain by 2030. Initiatives include energy decarbonisation, sustainable mobility practices, and partnerships with eco-conscious suppliers.

Investing in People: Diversity, Equity, and Well-being

The People pillar underlines diversity, equity, and inclusion within Almirall's workforce. The company actively works to close the gender pay gap and promotes a diverse and inclusive environment. Also, Almirall strengthens its commitment to employee well-being with enhanced corporate wellness initiatives and a new social action programme.

Empowering Patients: Expanding Positive Impact

Almirall remains dedicated to patient-centric care. Through the Patients pillar, the company strengthens engagement with patient organisations and embeds a patient-first mindset across all departments. Their goal is to positively impact over 1.8 million people with their dermatology portfolio by 2030.

Building Strong Partnerships: Sustainability Through Collaboration

The "Partners" pillar highlights Almirall's commitment to collaborating with suppliers on sustainability goals. By 2030, the company aims for a minimum 69% CO2 emissions reduction among suppliers with a carbon scorecard. In addition, Almirall implements sustainable procurement programmes and engages partners in its Net Zero Supplier Engagement initiative.

Guiding Principles: Transparency and Ethical Conduct

Act4Impact 2030 displays Almirall's commitment to ethical and transparent business practices. The Principles pillar focuses on responsibility and adherence to best practices. By 2030, the corporation wants to educate all employees with sustainability training and assess their impressions of the corporate culture.

Aligning with Purpose: Driving Sustainability for a Better Future

Almirall CEO and President, Carlos Gallardo, says, "In line with our long-term vision, and our commitment to patients, the medical community, and society, our updated sustainability strategy is a key element of our business strategy. Our Act4Impact strategy is at the heart of our decision making and aligned with our purpose to transform the lives of patients."

A Legacy of Sustainability

Almirall's commitment to responsible and sustainable operations is evident in their past achievements. The company has received multiple recognitions for its efforts, including a top 5% ranking in the pharmaceutical industry by Sustainalytics, an "A-" leadership score in Climate Change by CDP, and a platinum medal from Ecovadis, placing them among the top 1% of sustainable pharmaceutical companies.

For more company-related news

Discover an extensive network of ESG providers here

For more ESG event-related updates

Source: Almirall